These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30080931)

  • 1. Glycan-masking hemagglutinin antigens from stable CHO cell clones for H5N1 avian influenza vaccine development.
    Chen TH; Liu WC; Lin CY; Liu CC; Jan JT; Spearman M; Butler M; Wu SC
    Biotechnol Bioeng; 2019 Mar; 116(3):598-609. PubMed ID: 30080931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses.
    Lin SC; Liu WC; Jan JT; Wu SC
    PLoS One; 2014; 9(3):e92822. PubMed ID: 24671139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections.
    Chen TH; Yang YL; Jan JT; Chen CC; Wu SC
    Front Immunol; 2021; 12():692700. PubMed ID: 34335603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.
    Liu WC; Lin YL; Spearman M; Cheng PY; Butler M; Wu SC
    J Virol; 2016 Jul; 90(13):6085-6096. PubMed ID: 27099319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge.
    Liu G; Zhang F; Shi J; Tian G; Chen H; Yu K; Meng Q
    Vaccine; 2013 Nov; 31(46):5398-404. PubMed ID: 24055355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development.
    Chen TH; Liu WC; Chen IC; Liu CC; Huang MH; Jan JT; Wu SC
    Vaccine; 2019 Nov; 37(47):6933-6941. PubMed ID: 31383491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses.
    Zhou F; Wang G; Buchy P; Cai Z; Chen H; Chen Z; Cheng G; Wan XF; Deubel V; Zhou P
    J Virol; 2012 Jun; 86(12):6970-8. PubMed ID: 22496212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
    He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
    Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.
    Shoji Y; Chichester JA; Jones M; Manceva SD; Damon E; Mett V; Musiychuk K; Bi H; Farrance C; Shamloul M; Kushnir N; Sharma S; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():41-50. PubMed ID: 21266846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection.
    Du L; Zhao G; Sun S; Zhang X; Zhou X; Guo Y; Li Y; Zhou Y; Jiang S
    PLoS One; 2013; 8(1):e53568. PubMed ID: 23320093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Peeters B; Reemers S; Dortmans J; de Vries E; de Jong M; van de Zande S; Rottier PJM; de Haan CAM
    Virology; 2017 Mar; 503():83-93. PubMed ID: 28135661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
    Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
    J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.